Cannabis-induced oceanic boundlessness
Journal of Psychopharmacology March 28, 2021 Mitch Earleywine, Luna F. Ueno, Maha N. Mian et al. 36 citations
High doses of cannabis can produce subjective effects similar to those of the psychedelic psilocybin, but at a lower rate. In a survey, 17–19% of cannabis users reported a “breakthrough” experience, compared to 59% in psilocybin clinical trials. Heavier cannabis users reported lower scores. These effects may parallel the therapeutic benefits seen with psilocybin, suggesting potential for cannabis-assisted psychotherapy.